Arkolith/Insider Trading/WGS/Form 4

Stueland Katherine

CHIEF EXECUTIVE OFFICER, DirectorGeneDx Holdings Corp. (WGS) · full profile →Form 4 · filed Mar 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)9K$77.05$711K59K
Mar 16, 2026Option exercise(M)19K—$076K
Mar 16, 2026Sell(S)772$77.94$60K58K
Mar 16, 2026Sell(S)7K$76.35$548K68K
Mar 15, 2026Option exercise(M)12K—$057K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 16, 2026Option exercise(M)19K—$075K
Mar 15, 2026Option exercise(M)12K—$036K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001689575-26-000019) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML